Does quality of life of prostate cancer patients differ by stage and treatment?
- 4 December 2012
- journal article
- research article
- Published by SAGE Publications in Scandinavian Journal of Public Health
- Vol. 41 (1), 58-64
- https://doi.org/10.1177/1403494812467503
Abstract
Background: The lack of consensus amongst experts delineate how important it is for patients diagnosed with prostate cancer (PCa) to make an informed decision on available treatment options through an objective discussion of the risks and benefits. One of important benefits could be seen as patient’s quality of life (QoL) after treatment. We aimed to assess QoL differences in prostate cancer patients by stage and treatment for a population-based sample. Methods: The cross-sectional PCa patient population-based national level study for a prostate cancer patient population was performed. QoL was investigated with EORTC QLQ-C30. The analysis includes descriptive statistics and evaluation of differences in functional and symptom scales by stage and treatment group by predictors in the model. Results: Response rate was 79.1% ( N=514). The highest QoL scores were observed in localised PCa, active surveillance treatment group. The lowest scores were observed in advanced stages, chemotherapy treatment group. Between cancer stages, statistically significant differences were observed only in scales of emotional functioning ( p<0.001) and social functioning ( p<0.001). Between treatment groups, statistically significant differences were observed in scales of physical functioning ( p<0.001), role functioning ( p<0.001), emotional functioning ( p<0.001), and social functioning ( p<0.001). Conclusions: Our study highlighted statistically significant differences in QoL between cancer stages and treatment. Understanding how the QoL changes in relation with the selected treatment option can be important to the urologist and individual patient to have realistic expectations as well as to optimise treatment decisions for the prostate cancer patient when exist several alternatives.Keywords
This publication has 25 references indexed in Scilit:
- Factors affecting health-related quality of life in prostate cancer patientsScandinavian Journal of Urology and Nephrology, 2012
- Epidemiology of prostate cancer and treatment remarksWorld Journal of Radiology, 2012
- Prostate Cancer Screening—The Evidence, the Recommendations, and the Clinical ImplicationsPublished by American Medical Association (AMA) ,2011
- Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate CancerJAMA, 2010
- Health-Related Quality of Life up to Six Years After 125I Brachytherapy for Early-Stage Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Management of Prostate Cancer — Polling ResultsNew England Journal of Medicine, 2009
- Screening for prostate cancer (PC)—an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC)Urologic Oncology: Seminars and Original Investigations, 2008
- Screening for Prostate Cancer: An UpdateEuropean Urology, 2008
- Cost-Utility Analysis of Methadone Maintenance Treatment: A Methodological ApproachSubstance Use & Misuse, 2006
- A validation study of the domains of the core EORTC Quality of Life QuestionnaireQuality of Life Research, 1993